Century Therapeutics Files 2024 10-K
Ticker: IPSC · Form: 10-K · Filed: Mar 19, 2025 · CIK: 1850119
Sentiment: neutral
Topics: 10-K, financials, biotechnology
TL;DR
Century Therapeutics filed its 2024 10-K, detailing financials for year-end Dec 31, 2024. Check retained earnings & capital for performance.
AI Summary
Century Therapeutics, Inc. filed its 2024 10-K on March 19, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, focused on biological products, is incorporated in Delaware and headquartered in Philadelphia, PA. Key financial data such as retained earnings, additional paid-in capital, and accumulated other comprehensive income for the years 2022, 2023, and 2024 are detailed within the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Century Therapeutics' financial health and operational performance for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a biotechnology company, Century Therapeutics likely faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2023-12-31 — Prior Fiscal Year End (Comparison period for financial data)
- 2022-12-31 — Previous Fiscal Year End (Further comparison period for financial data)
Key Players & Entities
- Century Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-19 (date) — Filing date
- Philadelphia, PA (location) — Company headquarters
- 2836 (number) — Standard Industrial Classification code for Biological Products
FAQ
What is Century Therapeutics' primary business focus?
Century Therapeutics, Inc. is focused on Biological Products (NO DIAGNOSTIC SUBSTANCES), as indicated by its SIC code 2836.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 19, 2025.
What is the company's state of incorporation?
Century Therapeutics, Inc. is incorporated in Delaware (DE).
What are the key financial statement components reported for the fiscal years 2022-2024?
The filing reports on Retained Earnings, Additional Paid-In Capital, and Accumulated Other Comprehensive Income for the fiscal years ending December 31, 2022, 2023, and 2024.
Where is Century Therapeutics, Inc. headquartered?
The company's business address is located at 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA, PA 19104.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 19, 2025 regarding Century Therapeutics, Inc. (IPSC).